SuperworthHCW Biologics shares outstanding HCWB
Diluted shares outstanding, averaged over each quarter, from 2020.
- Latest quarter, to Jun 30, 2026
- 1.3M
- On a year earlier
- +347.6%
- more shares
HCW Biologics had 1.3M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 347.6% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 565.4K | +221% |
| FY2024 | 176.2K | +17% |
| FY2023 | 150K | +0% |
| FY2022 | 149.4K | +1% |
| FY2021 | 148.2K | +646% |
| FY2020 | 19.9K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 1.3M | +348% | |
| Q1 FY26 | 904.3K | +386% | |
| Q4 FY25 | 565.4K | +221% | |
| Q3 FY25 | 376.7K | +139% | |
| Q2 FY25 | 296.7K | +88% | |
| Q1 FY25 | 186.1K | +20% | |
| Q4 FY24 | 176.2K | +17% | |
| Q3 FY24 | 157.6K | +5% | |
| Q2 FY24 | 157.6K | +5% | |
| Q1 FY24 | 155.1K | +4% | |
| Q4 FY23 | 150K | +0% | |
| Q3 FY23 | 149.7K | +0% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on HCW Biologics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.